Related Experiment Video
Updated: Sep 8, 2025

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020
Targeting Cancer Cell Fate: Apoptosis, Autophagy, and Gold Nanoparticles in Treatment Strategies
Maria Anthi Kouri1,2, Alexandra Tsaroucha3, Theano-Marina Axakali4
1Department of Applied Medical Physics, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Gold nanoparticles (AuNPs) actively modulate cancer cell death pathways, including apoptosis and autophagy. This review explores how AuNPs can enhance cancer therapies by influencing these crucial cellular mechanisms for personalized treatment.
Area of Science:
- Nanotechnology and Cancer Biology
- Molecular Oncology
Background:
- Gold nanoparticles (AuNPs) are active agents in cancer biology, not just carriers.
- Apoptosis (programmed cell death) and autophagy (cell survival/death) are key pathways in tumor response.
- Understanding the interplay between AuNPs, apoptosis, and autophagy is crucial for novel cancer therapies.
Purpose of the Study:
- To review the molecular crosstalk between apoptosis and autophagy in cancer.
- To evaluate the impact of AuNPs on these critical cellular pathways.
- To explore the potential of AuNPs in overcoming cancer treatment resistance.
Main Methods:
- Literature review of studies on gold nanoparticles, apoptosis, and autophagy in cancer.
- Analysis of molecular mechanisms underlying AuNP interactions with cell death pathways.
- Evaluation of AuNPs' role in radiosensitization and drug delivery.
Main Results:
- AuNPs can enhance radiosensitization and improve chemotherapeutic precision.
- AuNPs show potential in circumventing resistance in aggressive or refractory tumors.
- The biological behavior of AuNPs is highly context-dependent due to their physicochemical nature.
Conclusions:
- AuNPs offer a unique strategy to reshape cancer cell fate by modulating apoptosis and autophagy.
- Integrating AuNPs, apoptosis, and autophagy presents an opportunity for mechanism-informed, patient-specific cancer therapies.
- Clinical translation requires addressing the complexity of AuNP behavior and tumor heterogeneity for precision medicine.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

